Generation of Genetically Modified Mice by Oocyte Injection of Androgenetic Haploid Embryonic Stem Cells  by Yang, Hui et al.
Generation of Genetically Modified Mice
by Oocyte Injection of Androgenetic
Haploid Embryonic Stem Cells
Hui Yang,1,6 Linyu Shi,1,6 Bang-An Wang,2,6 Dan Liang,1 Cuiqing Zhong,1 Wei Liu,2 Yongzhan Nie,4 Jie Liu,4 Jing Zhao,5
Xiang Gao,5 Dangsheng Li,3 Guo-Liang Xu,2,* and Jinsong Li1,*
1Group of Epigenetic Reprogramming, State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology
2Group of DNA Metabolism, State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology
3Shanghai Information Center for Life Sciences
Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
4State Key Laboratory of Cancer Biology and Institute of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi’an 710032,
China
5MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Nanjing University, Nanjing 210061, China
6These authors contributed equally to this work
*Correspondence: glxu@sibs.ac.cn (G.-L.X.), jsli@sibs.ac.cn (J.L.)
DOI 10.1016/j.cell.2012.04.002SUMMARY
Haploid cells are amenable for genetic analysis.
Recent success in the derivation of mouse haploid
embryonic stem cells (haESCs) via parthenogenesis
has enabled genetic screening in mammalian cells.
However, successful generation of live animals
from these haESCs, which is needed to extend the
genetic analysis to the organism level, has not been
achieved. Here, we report the derivation of haESCs
from androgenetic blastocysts. These cells, desig-
nated as AG-haESCs, partially maintain paternal
imprints, express classical ESC pluripotency
markers, and contribute to various tissues, including
the germline, upon injection into diploid blastocysts.
Strikingly, livemice can be obtained upon injection of
AG-haESCs into MII oocytes, and these mice bear
haESC-carried genetic traits and develop into fertile
adults. Furthermore, gene targeting via homologous
recombination is feasible in the AG-haESCs. Our
results demonstrate that AG-haESCs can be used
as a genetically tractable fertilization agent for the
production of live animals via injection into oocytes.
INTRODUCTION
In sexually reproductive organisms, haploid gametes—eggs and
sperm—mediate genetic transmission to the next generation.
However, both eggs and sperm are structurally specialized for
fertilization and cannot divide in vitro, preventing genetic manipu-
lation. An intriguing question is whether haploid cell lines from
either sex can be generated, cultured in vitro, and used in place
of gametes to create animal models (Kaufman et al., 1983; Yan
et al., 2000). Although mouse haploid embryos have been gener-
ated by different strategies in the last three decades (Kaufman,1978; Latham et al., 2002; Modlinski, 1975; Tarkowski and Ros-
sant, 1976), embryonic stem cells (ESCs) established from these
haploid embryos have turned out to display a diploid karyotype
(Kaufman et al., 1983). In humans, near-haploid cell lines have
been established from tumors (Carette et al., 2009; Kotecki
et al., 1999; Sukov et al., 2010), potentially due to the existence
of genetic mutations that stabilize the haploid genome. Recently,
relatively stable haploid ESCs (haESCs) frommouse parthenoge-
netic embryos have been established and applied in forward and
reverse genetic screens (Elling et al., 2011; Leeb and Wutz,
2011). These successes were made possible by the application
of 2i culture conditions (Buehr et al., 2008; Nichols et al., 2009a,
2009b; Nichols and Smith, 2011; Ying et al., 2008), together with
haploid cell enrichment using fluorescence-activated cell sorting
(FACS) (Elling et al., 2011; LeebandWutz, 2011). However, it is still
not clear whether haESCswith a specific genetic trait can be con-
verted into a mouse model either through germline transmission
after injection into blastocysts or through direct combination with
gametes of the opposite sex. Furthermore, it is critical that these
resultant mice can produce progeny themselves and deliver the
genetic traits to the next generation. We reasoned that, if haESCs
couldbegenerated fromandrogenetic (AG)blastocysts andstably
maintained in vitro, then they might be used to create mouse
models simply by injecting these haESCs into oocytes, a proce-
dure that is similar to intracytoplasmic sperm injection (ICSI).
In this study, we established protocols for the derivation of
haESCs from androgenetic blastocysts. These cells display
developmental potential in all examined aspects. More signifi-
cantly, injection of these haESCs into oocytes led to the genera-
tion of fertile animals.
RESULTS
Derivation of haESC Lines from Androgenetic
Blastocysts
To generate androgenetic haploid mouse embryos, we adopted
two different approaches. In the first set of experiments, weCell 149, 605–617, April 27, 2012 ª2012 Elsevier Inc. 605
Figure 1. Derivation of AG-haESCs
(A) Diagram for the generation of AG-haESCs from androgenetic blastocysts. The sperm injected into enucleated oocytes carries anOct4-EGFP transgene. hpa,
hours postactivation.
(B) An injected oocyte at 1 hr postactivation. Note that the sperm head has undergone decondensation based on Hoechst staining.
(C) Epigenetic modification of the male pronucleus (PN) formed from a sperm injected into an enucleated oocyte. (Left) 5 hmC (red) and 5 mC (green) appear
preferentially in themale or the female PN, respectively, in normal fertilized oocytes. (Right) DNA oxidation (5 hmC, red) also occurs in themale pronucleus formed
from a sperm injected into an enucleated oocyte.
(D) Fluorescence and phase-contrast image of androgenetic morulas and blastocysts developed from the injection of Oct4-EGFP sperm. Scale bar, 100 mm.
(E) Establishment of haES cell line (represented by AGH-OG-3) after three rounds of FACS enrichment for haploid cells. A DAPI filter was used to detect signal of
Hoechst-stained DNA. (Right) FACS data of diploid control ESCs for comparison.
(F) Colony morphology of established AG-haESC line (AGH-OG-1). Scale bar, 50 mm.
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performed nuclear transfer (NT), in which a haploid sperm head
from Oct4-EGFP transgenic mice (C57BL/6 background),
instead of a somatic nucleus, was injected into an enucleated
oocyte (Figure 1A). The sperm head underwent decondensation
and DNA oxidation based on Hoechst staining of the resulting
pronucleus and the appearance of a 5-hydroxymethylcytosine
(5 hmC) signal (Gu et al., 2011) (Figures 1B and 1C), reflecting
a profound remodeling of the donor nucleus in the enucleated
oocytes. Among the 909 oocytes that were reconstructed, 194
(21%) developed into blastocysts in vitro (Figure 1D), similar to
previously reported efficiency (Latham et al., 2002). After
removal of the zona pellucida, blastocysts were cultured in
a standard embryonic stem cell (ESC) culture system supple-
mented with 2i (Leeb and Wutz, 2011). Among 34 ES cell lines
that were generated, 4 lines (referred to as AGH-OG-1 to AGH-
OG-4) were identified and maintained with a subpopulation of
haploid cells through multiple rounds of FACS to enrich for
haploid cells (Figures 1E and 1F). In the second set of experi-
ments, androgenetic haploid blastocysts were generated by
removal of the female pronucleus from oocytes fertilized by
Actin-EGFP transgenic male mice (Figure S1A available online).
From 490manipulated fertilized oocytes, we obtained 82 blasto-
cysts (Figure S1B) and generated 5 ES cell lines. After multiple
rounds of FACS following passaging in vitro, one haploid ES
cell line (referred to as AGH-EG-1) was obtained (Figures S1C
and S1D). In summary, we derived 5 AG-haESC lines, which
could be expanded in vitro for more than 30 passages. Notably,
no AG-haESC line with the Y chromosome was observed in this
study (Figure 1G), confirming the earlier observations that haploid
or diploid Y chromosome-bearing androgenetic embryos could
not develop to the blastocyst stage (Latham et al., 2000, 2002).
Karyotyping of these ESCs revealed that all of themhad a haploid
set of 20 chromosomes (Figures 1H and S1E) at different
passages (Table S1). Comparative genomic hybridization
(CGH) of AG-haESC lines confirmed that the haploid cells sus-
tained genome integrity (Figures 1I and S1F and Table S2).
Pluripotency of AG-haESCs
AG-haESCs showed colony morphology similar to normal
diploid mouse ESCs. Immunostaining analysis revealed that ES
cell markers, including Nanog,Oct4, Sox2, and SSEA1, were ex-
pressed in haES clones (Figure 2A) and FACS-derived cells with
haploid DNA content (Figure S2A). Next, we compared the gene
expression profile of AG-haESCs with those of normal ESCs and
mouse embryonic fibroblasts (MEFs) from male individuals. To
avoid the influence of diploidized cells on the expression profile,
we collected samples after FACS of cells in the G1/G0 phase.
Clustering of these cells based on microarray expression data
showed a high correlation between AG-haESCs and the diploid
ESCs, but not MEFs (Figures 2B and S2B). To test the develop-(G) Presence of X chromosome and absence of Y chromosome in the AG-haESC l
shown. Normal diploid ESCs (female XX and male XY) were used as a control.
(H) Karyotype of AGH-OG-3 showing the normal haploid complement of 20 chro
(I) CGH analysis of haESCs (AGH-OG-3) andmalemouse kidney cells (C57BL/6). (
genomic alterations (amplifications or losses) were detected in haESCs.
See also Figure S1 and Tables S1 and S2.mental potential of AG-haESCs, we injected the Oct4-EGFP
(AGH-OG)- and Actin-EGFP (AGH-EG)-marked AG-haESCs
into diploid blastocysts of ICR origin. AG-haESCs could
contribute to the germline, as judged by Oct4-EGFP expression
in gonads of day 13.5 embryos (Figure 2C). Live-birth chimeric
mice with a high degree of somatic contribution by ESCs were
derived, and some of these chimeras survived to adulthood (Fig-
ure 2D). To determine whether haploidy can be maintained in
chimeras during development, we injected FACS-purified
Actin-EGFP-marked AG-haESCs into blastocysts and analyzed
the DNA content of progeny of the injected cells at different
developmental stages. We found that 2% of the enhanced green
fluorescent protein (EGFP)-labeled cells isolated from day 6.5
embryos were still haploid, but no haploid cells could be de-
tected in the embryos at later stages (Figures S2C–S2E and
2E). We also tested whether haploidy can be maintained upon
the differentiation of AG-haESCs in vitro. In vitro differentiation
of Oct-EGFP-marked AG-haESCs by retinoic acid treatment
for 6 days showed that both the undifferentiated and differenti-
ated populations contained haploid cells (data not shown).
These data indicate that haploidy can exist, at least transiently,
in differentiated cells. Nevertheless, repeated sorting is essential
to maintaining haploidy in ESCs (Elling et al., 2011). At present,
one cannot exclude the possibility that some essential differ-
ences may exist between ESCs and somatic cells (Kim et al.,
2011), which could contribute to the maintenance of haploidy
in ESCs. Taken together, our results demonstrate that haESCs
derived from androgenetic blastocysts, despite showing
a tendency of diploidization, are pluripotent as normal diploid
ESCs.
Partial Maintenance of Paternal Genomic Imprints
in AG-haESCs
Because paternal imprints established at the primordial germ
cell stage are propagated through fertilization and persist during
embryonic development, we next examined whether paternal
imprints are maintained in these AG-haESCs. We first compared
expression of imprinted genes in the haploid and control diploid
ESCs. As expected from the androgenetic origin of AG-haESCs,
all paternally imprinted genes, thus maternally expressed genes,
were downregulated except for the H19 gene (Figures 3A and
3B). In contrast, maternally imprinted genes (expressed from
the paternal allele) were upregulated (Figures 3A and 3B). These
observations suggested that the AG-haESCs largely maintained
a typical paternal imprinting status. To further assess epigenetic
inheritance, we performed bisulfite sequencing to analyze the
methylation profile of two paternally imprinted genes, Gtl2 and
H19, and one maternally imprinted gene, Snrpn. Whereas the
differentially methylated region (DMR) of H19 retained methyla-
tion at a reduced level, methylation at the Gtl2 DMR was largelyines. The result of genomic PCR using primers specific for sex chromosomes is
mosomes (19 + X).
Top) haESCs versus kidney cells. (Bottom) Kidney versus kidney cells. Nomajor
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Figure 2. Pluripotency of AG-haESCs
(A) Expression of ES cell markers in AG-haESCs. Representative immunostaining images of haES colonies are shown. Scale bar, 50 mm.
(B) Gene expression profiles of AG-haESCs. Gene expression profiles were clustered using all genes, and the Pearson correlation coefficient was calculated
(indicated by red). Five different AG-haESC lines cluster together, showing highly similar expression profiles. AG-haESCs show gene expression similar to the
control diploid E14 ESCs (male) but markedly different from mouse embryonic fibroblasts (MEFs, male). rep1, rep2, and rep3 indicate biological replicates.
(C) Gonads in day 13.5 embryos generated by injection of Oct4-EGFP-marked AG-haESCs into wild-type blastocysts. (Top) Bright-field image of gonads.
(Bottom) The same gonads under fluorescent illumination, showing Oct4-EGFP-positive cells. Scale bar, 100 mm.
(D) (Left) A chimeric mouse produced by injection of Actin-EGFP-marked AGH-EG-1 ESCs into normal diploid blastocysts. The extra-embryonic tissues were
host derived and thus not green fluorescent. (Right) A 7-week-old chimeric mouse obtained from the injection of AGH-OG-2 haESCs (C57BL/6, black) into ICR
blastocysts (albino).
(E) Flow analysis of DNA content of EGFP-positive and EGFP-negative cells isolated from a day 13.5 chimeric embryo. For FACS, a DAPI (for the Hoechst staining
signal) and a FITC filter (for EGFP) were used.
See also Figure S2.
608 Cell 149, 605–617, April 27, 2012 ª2012 Elsevier Inc.
Figure 3. Paternally Imprinted State of AG-haESCs
(A) List of imprinted genes with more than 2-fold expression difference between AG-haESCs and normal diploid ESCs E14, based on microarray analysis.
P, paternal allele; M, maternal allele.
(B) Expression of imprinted genes measured by quantitative real-time PCR (qPCR). The expression levels in AG-haESCs were relative to those in E14 cells, which
were set to 1. *0.01 < p < 0.05; **0.001 < p < 0.01. Error bars represent SD.
(C) Methylation analysis of the DMRs of Gtl2, H19, and Snrpn in mouse tail, sperm, and AG-haESCs (AGH-OG-3, passage 15). Open and filled circles represent
unmethylated and methylated CpG sites, respectively.
See also Figure S3.
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Figure 4. AG-haESCs Support Full-Term Embryonic Development when Injected into Oocytes
(A) Diagram of intracytoplasmic AG-haESC injection (ICAHCI) toward SC mice. After activation of the injected oocyte, the second polar body (PB) and pseu-
dopolar body (PPB) are excluded, respectively, from the oocyte and metaphase haESC nucleus, which results in a diploid embryo. The AG-haESCs used for
injection carry the EGFP transgene (green). PPN, pseudopronucleus derived from the injected haESC; hpa, hours postactivation.
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intact (Figure 3C). In contrast, the DMR of the Snrpn gene was
free of methylation (Figure 3C), reflecting the androgenetic origin
of the haploid cells. Methylation at the H19 DMR appeared to be
dynamic in cultured AG-haESCs, as the level fluctuated among
different passages (Figure S3). It should be noted that loss of
imprinting at the H19 locus was also observed in standard
diploid mouse and human ESCs upon prolonged culturing
(Dean et al., 1998; Humpherys et al., 2001; Rugg-Gunn et al.,
2005, 2007). Taken together, parental genomic imprints can be
generally maintained in AG-haESCs, albeit more dynamically
and less reliably at certain loci.
AG-haESCs Support Development following Injection
into Oocytes
We next tested whether AG-haESCs could be used in place of
sperm to support full-term development of mouse embryos
upon injection intomature oocytes. To this end, we performed in-
tracytoplasmic AG-haESCs injection (ICAHCI) (Figure 4A). In this
process, the genome of the resultant embryos combines
genomic material from the oocyte and the sperm-originated
AG-haESC. This is similar to artificial fertilization technology,
such as ICSI and round spermatid injection (ROSI), in which
sperm or round spermatid is injected into oocytes, respectively.
However, AG-haESCs, unlike sperm whose heads harbor
oocyte-activation factors (Kuretake et al., 1996), lack the ability
to activate the oocytes. Thus, reconstituted oocytes from
ICAHCI were activated in medium containing Sr2+ as in standard
mouse NT (Lin et al., 2011; Wakayama et al., 1998, 1999; Yang
et al., 2010). In a preliminary experiment, small cells, which
were surmised to be in the G1 phase (Wakayama et al., 1998,
1999), or FACS-selected haploid cells at the G1 phase were
used as donors for injection. We found that most injected
oocytes could not develop to the blastocyst stage in vitro (Table
S3). Because oocytes that are reconstructed using metaphase
ESCs as a donor develop into blastocysts at significantly higher
rates than interphase ESCs in nuclear transfer experiments (Ono
et al., 2001a, 2001b), we synchronized AG-haESCs at meta-
phase and selected small cells, most of which were haploid cells
in M phase, for ICAHCI. We observed that the injected haES
nucleus formed a pseudopronucleus that underwent reprogram-
ming like a male pronucleus (Figure 4B) (Gu et al., 2011). More-
over, the second polar body (PB) and the pseudopolar body
(PPB) were excluded from the spindle-chromosome complex
and the donor metaphase nucleus, respectively, resulting in a re-
constructed embryo containing diploid DNA. Injected oocytes(B) Reprogramming of injected AG-haESC. (Left and middle) Hoechst staining
munostaining of a reconstructed oocyte 6 hr after activation. Preferential staining
(right), respectively.
(C) Blastocysts generated by injection of AGH-OG ESCs (ICAHCI) or sperm (ICSI)
Scale bar, 100 mm.
(D) SC pups from ICAHCI using AGH-OG-3 haESCs. Pups and placentas obtaine
Growth-retarded SC pups that died within 1 hr after birth.
(E) Body and placenta weights of SC pups at birth. Control pups were from ICSI. ‘
ICSI pups (1.4 ± 0.2 g, n = 17) and could survive to adulthood. ‘‘Retarded’’ SC pu
1 hr after birth. Values are means ±SD. ***p < 0.001.
(F) Methylation state of the H19 DMR in a control ICSI pup (top), a normal SC pu
(G) Two 8-week-old SC mice derived from ICAHCI of AGH-OG-2 cells.
See also Figures S4 and S5 and Tables 1, S3, and S4.developed into blastocysts at a rate of 51% (Figure 4C and Table
S3), similar to that in control ICSI experiments (Table S3). To
examine whether these blastocysts had a normal euploid karyo-
type, we analyzed 19 ESC lines established from 40 blastocysts
by measuring their DNA content using FACS. Seventeen ESC
lines were diploid (Figure S4A and Table S4), reflecting
a successful ICAHCI procedure. The other two cell lines were
triploid (Figure S4A and Table S4), suggesting that a few diploi-
dized AG-haESCs had been erroneously selected for injection.
We next tested the developmental potential of these ICAHCI
embryos by transferring two-cell embryos or blastocysts into
oviducts or uteri of pseudopregnant females, respectively. Out
of 553 transferred two-cell embryos and 424 blastocysts derived
from all five AG-haESC lines (passage 7 to passage 22), a total of
46 live pups were recovered by caesarean section (C section) at
19.5 days of gestation (Figures 4D and S4B and Table 1). All of
them were females, as expected from the injection of X-bearing
AG-haESCs. Genotyping revealed that they carried the EGFP
transgene that originated from the AG-haESCs (Figure S4C).
We refer to these mice as semicloned (SC) (Yanagimachi,
2005; Yi et al., 2009) because they were derived by combining
an AG-haESC donor with a normal oocyte. The rate of SC mice
born was 4.5% of the transferred blastocysts or 4.9% of
the transferred two-cell embryos (Table 1), similar to the rate of
standard NT using conventional ESCs (Li and Mombaerts,
2008; Wakayama et al., 1999). However, differing from cloned
mice generated from ESCs that display an overgrowth pheno-
type (Rideout et al., 2001), SC mice were either normal with
a typical newborn body weight or developmentally retarded
(Figures 4D, 4E, and S4B). All retarded pups died within 1 hr of
birth, reminiscent of what has been observed in bimaternal
mice generated by the construction of oocytes from fully grown
oocytes and nongrowing oocytes that contain a single deletion of
the H19 DMR (Kono et al., 2004) or double deletions of the H19
DMR and the Dlk1-Dio3 intergenic germline-derived DMR (Ka-
wahara et al., 2007). We then examined the methylation status
of imprinted genes at birth and observed that methylation was
absent at the H19 DMR in growth-retarded mice, whereas it
was normal in alive newborn mice (Figures 4F and S5A–S5C).
Interestingly, growth-retarded pups were obtained at a higher
frequency from ICAHCI using the cells of later passages (from
AGH-OG-3, Table 1) that harbored a more severe loss of the
H19methylation imprint (Figure S3E). Consistently, gene expres-
sion analysis showed that normal SC mice had similar expres-
sion patterns to control mice in two pairs of interrelated imprintedimages of reconstructed oocytes at 0 and 1 hr after activation. (Right) Im-
of 5 hmC (red) and 5 mC (green) was observed in PPN and female pronucleus
into oocytes. The donor haESCs and sperm carried theOct4-EGFP transgene.
d by C section from a pseudopregnant mouse at E19.5 are shown. (Asterisks)
‘Normal’’ SC pups had a similar birth weight (1.4 ± 0.18 g, n = 21) as the control
ps had a smaller size at birth (body weight: 0.6 ± 0.13 g, n = 22) and died within
p (middle), and a retarded SC pup (bottom).
Cell 149, 605–617, April 27, 2012 ª2012 Elsevier Inc. 611
Table 1. In Vivo Development of ICAHCI Embryos
ES Cell
Line
Passage
Number
Embryo
Stage
Number of
Embryos
Transferred
Number of
Implantations
(% of Transferred
Embryos)
Number of
Growth-Retarded
Pups (% of
Transferred Embryos)
Number of
Normal Pups
(% of Transferred
Embryos)
Number of Pups
Surviving to
Adulthood (% of
Transferred Embryos)
AGH-OG-1 p22 two-cell
embryo
68 31 3 0 0
AGH-OG-3 p14 two-cell
embryo
102 41 1 3a NDb
p15 two-cell
embryo
45 25 2 3 2
p17 two-cell
embryo
112 62 2 2 1
p22 two-cell
embryo
102 43 3 0 0
AGH-EG-1 p22 two-cell
embryo
124 52 4 4 3
Subtotal 553 254 (45.9) 15 (2.7) 12 (2.2) 6 (ND)
AGH-OG-1 p7 blastocyst 80 37 2 1 1
p9 blastocyst 37 24 2 0 0
AGH-OG-2 p7 blastocyst 86 62 1 5 4
AGH-OG-4 p9 blastocyst 44 23 1 1 1
p11 blastocyst 68 39 1 1 1
AGH-EG-1 p10 blastocyst 85 53 1 1 1
p16 blastocyst 24 16 2 0 0
Subtotal 424 254 (59.9) 10 (2.4) 9 (2.1) 8 (1.9)
Sperm blastocyst 56 40 (71.4) 0 (0) 17 (30.4) 14 (25)
aThese three normal mice were dissected for gene expression analysis on the day of recovery. See also Figures 4, S4, and S5.
bNot determined.genes (Igf2 and H19, and Dlk1 and Gtl2), whereas growth-
retarded pups exhibited a significantly lower Igf2 expression in
major organs than control mice (Figure S5D).
Normal-weight SC pups were successfully nursed by foster
mothers, andmost of them (14/18) grew to adulthood (Figure 4G).
To test whether the SC mice could deliver the Oct4-EGFP trans-
gene to the next generation by germline transmission, we
dissected one newborn and one 4-week-old SC pup derived
from AGH-OG-1 and observed that ovaries and germinal vesicle
(GV) oocytes were EGFP positive (Figure 5A). Furthermore, one
SC mouse, which was superovulated and mated with a normal
B6D2F1 male, delivered a litter of 16 pups (Figure 5B). Oct4-
EGFP-positive pups accounted for 50% (8/16), conforming to
the expected Mendelian ratio (Figure 5C), as the SC mother
was heterozygous for Oct4-EGFP. Importantly, transgene-posi-
tive pups were found among both female andmale progeny (Fig-
ure 5D), indicating that female SCmice derived fromAG-haESCs
are capable of normal gametogenesis. These data demonstrate
that AG-haESCs, when injected into oocytes, can introduce
genetic traits into the resulting SC mice, who further transmit
to offspring.
Gene Targeting in AG-haESCs
Having demonstrated the developmental potential of AG-
haESCs by both blastocyst injection and ICHACI, we next exam-612 Cell 149, 605–617, April 27, 2012 ª2012 Elsevier Inc.ined whether specific genetic alterations can be introduced into
these haESCs through homologous recombination. To avoid
potential perturbation in cellular function, a conditional gene tar-
geting strategy was used tomodify the locus of Vwce, a gene en-
coding a ‘‘vonWillebrand factorC and EGFdomains’’-containing
protein presumably involved in the Wnt-signaling pathway (Du
et al., 2010). The targeting construct contains a left and a right
homologous arm of 4.9 and 5.6 kb, respectively, flanking
a PGK-neo drug selection cassette and a genomic region of
3.5 kb encompassing exons 2–4 (Figure 6A). Upon electropora-
tion with the linearized construct, cells were selected in G418
and ganciclovir for gene targeting. Control experiments, in which
cells were selected only in G418, indicated an average of a 6-fold
enrichment with the G418/ganciclovir double-selection regime.
When 90 double-resistant colonies, derived from two separate
experiments, were analyzed by PCR using primer pairs P1-P2
and P3-P4, 43 positive clones were found (Figure 6B). Among
these, 12 clones (13%) were identified to contain only the tar-
geted allele, whereas the rest had an additional wild-type allele,
as judged on the PCR result from the primer pair P5-P6. From
four randomly picked targeted clones, AG-haESC lines (referred
to as AGH-Vwce) were established through consecutive
passages, followed by FACS sorting for haploid cells (Fig-
ure 6C). The identification of stable clones that contain a signifi-
cant haploid subpopulation carrying the targeted allele but
Figure 5. Genetic Transmission of AG-
haESCs to Offspring of SC Mice
(A) Ovary (top) dissected from a newborn SC pup
generated from AGH-OG-1 carrying an Oct4-
EGFP transgene and GV oocytes (bottom) isolated
from the ovary of a 4-week-old SC mouse. Green
fluorescence indicates Oct4-EGFP-expressing
germ cells. Scale bars, 200 mm (top) and 100 mm
(bottom), respectively.
(B) Progeny with an SC mother derived from
AGH-OG-1 cells.
(C) Genotyping analysis of the progeny. Note that
50% (8/16) of the progeny of an SC mother are
Oct4-EGFP positive.
(D) Germline contribution of AG-haESC in both
sexes of offspring of the SC mother. Two left
panels show the Oct4-EGFP transgene expres-
sion in seminiferous tubules of a 1-week-old male
F2 pup. Oct4 expression is detected in the entire
population of gonocytes in this newborn male, as
expected (Pesce et al., 1998). The two right panels
show Oct4-EGFP reporter expression in GV
oocytes isolated from the ovary of a 2-week-old
female F2 pup. The EGFP signal recapitulates the
Oct4 expression in developing oocytes. Scale
bars, 100 mm.lacking the wild-type allele indicates that homologous recombi-
nation has occurred in haploid cells following electroporation of
the targeting construct and thus that AG-haESCs are amenable
to standard gene targeting manipulation.
We next tested whether the gene-targeted AG-haESCs have
the capacity to support full-term embryo development. We con-
structed 444 embryos via ICAHCI using Vwce-targeted AG-
haESCs, and from these embryos, we obtained one live-birth SC
pup (Figure S6A). Genotype analysis confirmed the existence of
the targetedallele in thewholebodyof thepup (FigureS6B).Unfor-
tunately, the pup was growth retarded and died shortly after birth,
whichmight beexpected considering the lossofH19 imprint in the
pup and in the original Vwce-targeted AG-haESCs (Figure S6C).
The overall low success rate of obtaining live-birth gene-targeted
pups is mostly likely due to the loss of imprint (including the H19
locus) in the Vwce-targeted AG-haESCs, which represented
a late-passage line (passage 28) and had been through an addi-
tional period of culturing due to selection of the targeted allele.
Nevertheless, our results provide the proof of principle that genet-
icallymodifiedanimalscanbeobtainedvia the ICAHCI technology
using AG-haESCs that harbor a modified allele.
DISCUSSION
Recently, two independent groups (Elling et al., 2011; Leeb and
Wutz, 2011) have established haESCs from mouse embryos,Cell 149, 605–6enabling functional screening for genes
involved in diverse cellular and develop-
mental processes (Schimenti, 2011). In
both reports, haESCs were generated
from parthenogenetic blastocysts,
implying that these cells probably main-tain a maternal imprinting status that is established during
oogenesis. If such is the case, then these haESCs may not
support full-term development of embryos after injection into
MII oocytes because the resulting embryos are parthenoge-
netic and would fail to develop to term (McGrath and Solter,
1984; Surani and Barton, 1983; Surani et al., 1984, 1990). The
possible strategies to generate mice from parthenogenetic
haESCs are either to replace the chromosome-spindle complex
(CSC) of MII oocytes with that from haESCs, followed by ICSI
into reconstituted oocytes (Liu et al., 2001), or to inject haESC
into diploid blastocysts to derive chimeric mice with germline
transmission. However, these strategies are technically compli-
cated or have not been successfully tested (Elling et al., 2011;
Leeb and Wutz, 2011). This leaves an open question of whether
haESCs can be converted into mouse models (Schimenti,
2011), which is a prerequisite for extending genetic analysis
at the cellular level to the organism level. In our study, we
generated multiple haESC lines from androgenetic blastocysts
and demonstrated that AG-haESCs could be used to support
full-term embryonic development following injection into
oocytes, which results in successful trait transmission into live
animals.
During normal fertilization, a sperm carrying paternal imprints
enters an egg with maternal imprints, resulting in a new
organism. However, both parthenogenetic and androgenetic
embryos fail to develop to term (McGrath and Solter, 1984;17, April 27, 2012 ª2012 Elsevier Inc. 613
Figure 6. Genetic Manipulation in AG-haESCs
(A) Strategy for homologous recombination to target the Vwce gene. Coding exons are shown as black boxes, and the 50 noncoding part of exon 1 is shown as
a blank box. The Flippase recognition target (Frt) sites flanking the neo selection marker are shown as blank triangles, and the loxP sites flanking the target region
are shown as gray triangles. PCRprimers used for genotyping AG-haESC clones are shown as horizontal arrows. Correctly targeted haESC cloneswould give rise
to a 4.9 kb fragment using primers one and two (from the region spanning the left arm) and a 5.6 kb fragment using primers three and four (from the region
spanning the right arm). Diploid targeting can be detected by using primers P5-P6 as an additional shorter product and would arise from the untargeted wild-type
allele lacking the right loxP site. AG-haESCs from AGH-EG-1 (passage 28) were used for gene targeting.
(B) Confirmation of gene targeting in AGH-Vwce cells. The PCR genotyping result of genomic DNA isolated from drug-selected AG-haESC lines is shown. PCR
primer pairs used are indicated at the left. A targeted normal diploid ES cell line was used as a control to reveal the existence of two alleles (lane one) and the
untargeted AG-haESC line as negative control (lane two).
(C) Propagation of targeted AGH-Vwce lines with a stable haploid population. Targeted cell lines were established from G418-resistant clones through multiple
passages and FACS enrichment for haploid cells.
See also Figure S6.Surani and Barton, 1983; Surani et al., 1984, 1990), showing that
completion of embryogenesis requires the contribution of both
the male and the female gamete genomes of different parental
imprints. AG-haES cell lines, derived from sperm, are capable
of ‘‘fertilization’’ of oocytes and can be used in place of sperm
to support full-term development of mouse embryos after injec-
tion into oocytes, presumably thanks to the maintenance of
typical male imprinting status in these cells. The efficiency of
SCmice derivation by ICAHCI is lower than that of ICSI, suggest-
ing that differences in epigenetic features, including parental
methylation imprints, exist between AG-haESCs and sperm.
Further investigation into the underlying differences will not
only aid our understanding of the early reprogramming events
following natural fertilization, but may also yield clues to improve
the sperm-like features of AG-haESCs for more efficient genera-
tion of SC animals via ICAHCI.
SC mice fall into two readily distinguishable groups based on
the birth weight of pups and placentas: the growth-retarded
mice that could not survive the early postnatal period and those
with normal birth size that could grow to adulthood and establish614 Cell 149, 605–617, April 27, 2012 ª2012 Elsevier Inc.fertility. A plausible interpretation is that AG-haESCs used for
ICAHCI are a heterogeneous population containing both epige-
netically normal cells functionally equivalent to a mature sperm
and aberrant cells carrying errors in genomic imprinting that
are less compatible with embryonic and/or postnatal develop-
ment. This distinction of subpopulations is indeed reflected by
the methylation variation at the H19-imprinted gene seen in
AG-haESCs (Figures 3C and S3). Consistently, the smaller SC
pups born from ICAHCI are characterized by hypomethylation
at H19, whereas the mice with normal size are marked with the
expected paternal methylation (Figures 4F and S5). It is known
that the in vitro culture environment can cause alterations in
the imprinting status of H19 in human (Rugg-Gunn et al., 2007)
and mouse diploid ESCs (Humpherys et al., 2001), especially
during prolonged passaging (Rugg-Gunn et al., 2005), and that
abnormal imprinting would result in aberrant development of
ESC-derived embryos (Dean et al., 1998). Therefore, a future
task is to define appropriate derivation and culture conditions
that would enable the relatively stable maintenance of imprinting
marks in AG-haESCs, which would facilitate the potential
applications of these cells. One intriguing application is the
generation of gene-modified animals via ICAHCI in other species
for which conventional ESCs can be obtained but fail to support
the production of chimeras (and thus, gene-modified animals),
such as the monkey (Tachibana et al., 2012).
In summary, we have demonstrated that the AG-haESCs can
be used as a genetically tractable fertilization agent for yielding
live-bornmice via injection into oocytes (the ICAHCI technology).
By being amenable to gene manipulations and supporting trans-
mission of genetic information to offspring, these haploid cells
open new avenues for the generation of genetically modified
animals. The next challenge is to improve the sperm-like features
of the AG-haESCs by optimizing their epigenetic makeup
without compromising their genetic integrity and proliferative
capacity.EXPERIMENTAL PROCEDURES
Animal Use and Care
All animal procedures were performed under the ethical guidelines of the Insti-
tute of Biochemistry and Cell Biology.Preparation of AG-Haploid Embryos
Spermatozoa of Oct4-EGFP transgenic male mice (C57BL/6 background)
were collected and prepared for ICSI according to the methods performed
previously (Kimura and Yanagimachi, 1995; Yang et al., 2011). B6D2F1
(C57BL/6 X DBA2) female mice were used as oocyte donors. To generate
AG-haploid embryos, we used two strategies. In the first strategy, standard
NT (Lin et al., 2011; Wakayama et al., 1998) was performed, in which somatic
donors were replaced by sperm heads. Briefly, oocytes were obtained 14 hr
after human chorionic gonadotropin injection and enucleated in a droplet of
HEPES-CZB medium containing 5 mg/ml cytochalasin B (CB) using a blunt
Piezo-driven pipette. After enucleation, a single sperm head was injected
into oocyte cytoplasts. The reconstructed oocytes were cultured in CZB
medium for 1 hr and then activated for 5–6 hr in activation medium containing
10 mM Sr2+. Following activation, all of the reconstructed embryos were
cultured in potassium simplex optimization medium (KSOM) with amino acids
at 37Cunder 5%CO2 in air. In the second strategy, B6D2F1 femalemicewere
mated with Actin-EGFP transgenic male mice (C57BL/6 background), and
zygotes were harvested at PN3 stage. Female pronuclei, which were distin-
guished from male pronuclei on the basis of their size and distance from the
polar body, were removed from zygotes of PN3–4 stages by piercing the
zona pellucida using Piezo drive (Prime Tech) and aspirating using a microma-
nipulator (Gu et al., 2011). The zygotes containing a male pronucleus were
cultured in KSOM with amino acids at 37C under 5% CO2 in air. The recon-
structed embryos that reached the morula or blastocyst stage by 3.5 days in
culture were transferred to ES cell medium.Derivation of AG-haESCs
Morulas or blastocysts were selected to generate ES cell lines as described
(Yang et al., 2010). The zona pellucida was removed using acid Tyrode solu-
tion. Each embryo was transferred into one well of a 96-well plate seeded
with ICR embryonic fibroblast feeders in ESC medium supplemented with
20% knockout serum replacement, 1,500 U/ml leukemia inhibitory factor
(LIF), 3 M CHIR99021, and 1 M PD0325901 (Leeb and Wutz, 2011; Ying
et al., 2008). After 4–5 days in culture, the colonies were trypsinized and trans-
ferred to a 96-well plate with a fresh feeder layer in fresh medium. Clonal
expansion of the ESCs proceeded from 48-well plates to 6-well plates with
feeder cells and then to 6-well plates for routine culture. To sort haploid cells,
ESCs were trypsinized, washed by Dulbecco’s Phosphate-Buffered Saline
(GIBCO), and then incubated with 15 mg/ml Hoechst 33342 in a 37C water
bath. Subsequently, the haploid 1n peak was purified using BD FACS AriaII
for further culturing. For analysis, after fixation in 70% ethanol, cells weredigested by 20 mg/ml RNase A and stained with 50 mg/ml propidium iodide
(PI). Analytic flow profiles were recorded by BD LSRII SORP.
Karyotype Analysis
ESCs were incubated with 0.4 mg/ml demecolcine (Sigma) for 1 hr. After tryp-
sinizaiton, the ESCs were resuspended in 0.075 M KCl at 37C for 30 min.
Hypotonic solution-treated cells were fixed in methanol:acetic acid (3:1 in
volume) for 30 min and dropped onto precleaned slides. After being incubated
in 5 M HCl, cells were stained with Giemsa for 15 min. More than ten meta-
phase spreads were analyzed.
Immunostaining
Cells on glass coverslips were fixed in PBS supplemented with 4% parafor-
maldehyde for 15 min at room temperature (RT). The cells were then permea-
bilized using 0.2%Triton X-100 in PBS for 15min at RT. The cells were blocked
for 30 min in 1% BSA in PBS. All primary antibodies against Oct4 (sc-5279,
Santa Cruz), Nanog (RCAB002P-F, Reprocell), SSEA-1 (mab4301, Millipore),
andSox2 (ab5603, Millipore) were diluted in the same blocking buffer and incu-
bated with the samples overnight at 4C. The cells were treated with a fluores-
cently coupled secondary antibody and then incubated for 1 hr at RT. The
nuclei were stained with Hoechst 33342 (Sigma) for 5 min at RT.
Injection of AG-haESCs into Diploid Blastocysts
Blastocyst injection was performed as described previously (Jiang et al.,
2011). Briefly, diploid blastocysts were collected from the uteri of superovu-
lated ICR females at 3.5 days postcoitum (dpc) and kept in KSOM medium
with amino acids until haESCs injection. Prior to blastocyst injection,
AG-haESCs were trypsinized, resuspended in Dulbecco’s modified Eagle’s
medium without LIF, and kept on ice. A flat-tip microinjection pipette was
used for the ES cell injection. More than 100 ESCs were picked up at the
end of the injection pipette, and about 10–15 ESCs were injected into the blas-
tocyst cavity. The blastocysts were kept in KSOM with amino acids until
embryo transfer. Eight to ten injected blastocysts were transferred into each
uterine horn of 2.5 dpc of pseudopregnant ICR females. Pregnant recipients
were subjected to caesarean section on day 19.5 of gestation.
DNA Content Analysis of Cells from Chimeras
Chimeric fetuses generated by injection of AGH-EG-1 into diploid blastocysts
were dissected at days 6.5, 8.5, 10.5, and 13.5 of gestation. Dissociation to
single cells was performed by treatment with 0.05% trypsin/EDTA at 37C
for 30 min. Cells were fixed in 4% PFA in 4C, following Hochest 33342 stain-
ing. EGFP-positive and EGFP-negative cells were isolated by FACS, and DNA
content was determined by flow analysis. For FACS, a DAPI filter (for the
Hoechst staining signal) and a FITC filter (for GFP) were used.
Quantitative Reverse Transcription PCR
Total RNA was isolated from the cells using Trizol reagent (Invitrogen). One
microgram of total RNA was reverse transcribed using a First Strand cDNA
Synthesis kit (TOYOBO). Real-time quantitative PCR reactions were set up
in triplicate using the SYBR Green Realtime PCR Master Mix (TOYOBO) and
run on a Bio-Rad CFX96. All of the gene expression levels were normalized
to the internal standard gene, Gapdh. Primer information is presented in
Table S5.
Bisulphite Sequencing
To obtain mouse sperm DNA and tail genomic DNA, samples were pretreated
with dithiothreitol for 3 hr (for sperm only), following proteinase K lysis and
phenol-chloroform extraction. For DNA methylation analysis in FACS-derived
AG-haESCs, cumulus cells, and oocytes, bisulphite conversion was per-
formed in agarose beads as described (Hajkova et al., 2002). The PCR prod-
ucts were cloned into pMD19-T vectors (Takara), and individual clones were
sequenced by Invitrogen, Shanghai. Bisulphite primer information is presented
in Table S5.
Intracytoplasmic AG-haESCs Injection
To generate SC embryos, AG-haESCs at G1 or M stage were used for intracy-
toplasmic injection. AG-haESCs were trypsinized, washed three times withCell 149, 605–617, April 27, 2012 ª2012 Elsevier Inc. 615
HEPES-CZB medium, and suspended in HEPES-CZB medium containing
3% (w/v) polyvinylpyrrolidone. In the first set of experiments, small AG-
haESCs, which were presumably at G1 stage or FACS-derived G1 phase
AG-haESCs, were selected for injection. In the second set of experiments,
AG-haESCs were arrested at M phase by culturing in medium containing
0.05 mg/ml demecolcine for 8 hr. Each nucleus from G1 phase donor cells or
M phase chromosomes from M phase cells was injected into an MII-arrested
oocyte using a Piezo-drill micromanipulator. The reconstructed oocytes were
cultured in CZB medium for 1 hr and then activated for 5–6 hr in activation
medium without CB. Following activation, all of the reconstructed embryos
were cultured in KSOMmediumwith amino acids at 37C under 5%CO2 in air.
Embryo Transfer and Cesarean Section
ICAHCI embryos were cultured in KSOM medium until the two-cell stage or
blastocyst stage. Thereafter, 15–20 two-cell embryos or 8–10 blastocysts
were transferred into each oviduct or uterus of pseudopregnant ICR females
at 0.5 dpc or 2.5 dpc, respectively. Recipient mothers were euthanized at
19.5 days of gestation, and the pupswere quickly removed from the uteri. After
cleaning fluid from their air passages, the pups were kept in a warm box
supplied with oxygen. Surviving pups were raised by lactating mothers.
Microarray Analysis
RNA from biological triplicates of diploid ESCs (E14), five independently
derived haploid ESCs (AGH-OG-1 passage 14, AGH-OG-2 passage 15,
AGH-OG-3 passage 12, AGH-OG-4 passage 14, and AGH-EG-1 passage 15),
and duplicates of mouse embryonic fibroblasts (MEFs) from male individuals
were extracted using the RNeasy kit (QIAGEN). Gene expression analysis on
Affymetrix GeneChip 430 2.0 arrays was performed by Imagenes. The data
were analyzed using Genespring GX software (Agilent Technologies). The
labeling and hybridization were performed at the Shanghai Biochip Company
according to the protocols in the Affymetrix GeneChip 30 IVT Express Kit
User Manual. The relatedness of transcription profiles was determined by
calculating the Pearson correlation coefficient (r).
DNA samples (from AGH-OG-2, AGH-OG-3, and AGH-EG-1) for CGH
experiments were extracted and sent to the CapitalBio Corporation (Changp-
ing District, Beijing) for CGH analysis using NimbleGen 3x720K mouse whole-
genome tiling arrays with an average probe spacing of 3.5 kb. Adult male
C57BL/6 kidney DNA was used as a reference.
Gene Targeting
To generate the Vwce targeting vector, DNA fragments for the 50 and 30
homology arms were cloned from a BAC clone from mouse (C57BL/6)
genomic DNA by the standard recombineering (recombination-mediated
genetic engineering) technique. The left arm consisted of a 4.9 kb 50 region
(including exon 1), and the right arm was a 5.6 kb fragment covering the 30
coding region of exons 5 and 6. The two arms were confirmed by sequencing.
The AG-EG-1 haES cell line (passage 25) was used for gene targeting. Approx-
imately 3 hr after a medium change, the ESCs were trypsinized and resus-
pended as a single-cell suspension at a density of 1 3 107 cell/ml in the
Ca2+/Mg2+ -free PBS and then electroporated with 25 mg of the pL253-Vwce
targeting vector in a 0.4 cm wide sterile cuvette. The condition for a typical
single pulse was 260 V, 500 mF. After storing at room temperature for 5 min,
the cells were plated on a 10 cm dish with neomycin-resistant MEF feeder
cells. After 24 hr, drug selection was started by replacing medium with ES
selection medium containing about 200 mg/ml G418 and 2 mM ganciclovir,
and the selection medium was changed every day. Colonies were picked
10–12 days later. The harvested colonies were trypsinized and transferred to
a 24-well plate with ES selection medium containing 100 mg/ml of G418 and
2 mM of ganciclovir. After 3–5 days in culture, G418-resistant colonies were
screened for homologous recombination by long-range PCR using primers
(P1–4) spanning the left and right recombination arms, respectively. The primer
sequences are listed in Table S5.
Statistic Analysis
Differences of gene expression levels between groups were analyzed by
means of Student’s t test. All statistical analyses were done applying SPSS
software 13.0.616 Cell 149, 605–617, April 27, 2012 ª2012 Elsevier Inc.ACCESSION NUMBERS
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